Healthcare Service Provider

Dr Lalchandani Labs Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 31 filings·Updated 13 Oct 2026
Showing 10 of 31 filings.
13 Oct 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dematerialisation processing completed; securities listed; certificates mutilated and owner updated

Processing of dematerialisation requests

  • Registrar and Share Transfer Agent confirmed processing and reported acceptance/rejection to depositories.

Listing of dematerialised securities

  • Securities dematerialised have been listed on the stock exchanges.

Certificate handling and ownership update

  • Physical certificates were mutilated and cancelled; owner updated in records within timeline.
Filed 16:14View Source
30 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Dr Lalchandani Labs Limited – Trading Window closed from Thursday, October 01, 2026 and will be opened 48 hours after the declaration of unaudited financial results for the half year ended September 30, 2026

Dr Lalchandani Labs Limited – Trading Window closed from Thursday, October 01, 2026 and will be opened 48 hours after the declaration of unaudited financial results for the half year ended September 30, 2026

Filed 17:23View Source
17 Sept 20261 filing
Company UpdateGeneral

AGM extension approved; AGM to be held by 31 December 2026

AGM extension approved

  • Extension of time to hold AGM for FY 2025-26 granted by ROC Delhi.
  • AGM originally due on or before 30 September 2026.
  • ROC order approves extension up to three months dated 17 September 2026.
  • AGM to be held no later than 31 December 2026.
  • Exact AGM date, venue, and notice to be communicated subsequently.
  • Reason: ill health of Chairperson and related difficulties.
  • Application SRN AC6063647 filed on 15 September 2026.
  • ROC advised careful future compliance with Companies Act provisions.
  • Accounting year ended 31 March 2026.
Filed 20:27View Source
17 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dematerialisation processing confirmed, securities listed, and physical certificates cancelled under Reg 74(5)

Dematerialisation status

  • Dematerialisation requests were processed and confirmed to depositories during the quarter.
  • Securities dematerialised have been listed on the exchanges where the earlier issue is listed.
  • Physical certificates were mutilated and cancelled after verification.
  • Depository name substituted as registered owner in the records within the prescribed time limit.
Filed 13:59View Source
4 May 20261 filing
OthersFormat of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2

<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 12:48View Source
13 Apr 20262 filings
Company UpdateGeneral

Reply to the clarification sought by exchange dated April 13, 2026

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:44View Source
Company UpdateClarification

The Exchange has sought clarification from Dr Lalchandani Labs Ltd on April 13, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:30View Source
27 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Trading Window Closure for March 31, 2026

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 16:45View Source
6 Mar 20261 filing
Company UpdateNewspaper Publication

post issue newspaper advertisements under Regulation 92

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 11:39View Source
5 Mar 20261 filing
Insider Trading / SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anuraag Gambhir

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 15:49View Source
Showing 10 of 31 filings